ProPhase Labs, Inc. Operating Income Loss

• ProPhase Labs, Inc. showed a decrease of -82.0% in Operating Income Loss from 2023 to 2024.
• This data is from ProPhase Labs, Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
• XBRL data for this metric is available from 2009 to 2024 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2009 to 2024), ProPhase Labs, Inc.'s Operating Income Loss has declined by 881.7%.
• Historical annual values: Fiscal year 2024: -$38.63 million | Fiscal year 2023: -$21.22 million | Fiscal year 2022: $23.60 million | Fiscal year 2021: $9.80 million | Fiscal year 2020: -$2.08 million | Fiscal year 2019: -$3.24 million | Fiscal year 2018: -$1.63 million | Fiscal year 2017: -$3.99 million | Fiscal year 2016: -$2.66 million | Fiscal year 2015: -$3.58 million | Fiscal year 2014: -$7.83 million | Fiscal year 2013: $416.0 thousand | Fiscal year 2012: -$1.10 million | Fiscal year 2011: -$2.74 million | Fiscal year 2010: -$3.59 million | Fiscal year 2009: -$3.94 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026